Imricor Medical Systems Inc
ASX:IMR

Watchlist Manager
Imricor Medical Systems Inc Logo
Imricor Medical Systems Inc
ASX:IMR
Watchlist
Price: 1.265 AUD -4.17% Market Closed
Market Cap: 341.8m AUD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one IMR stock under the Base Case scenario is hidden AUD. Compared to the current market price of 1.265 AUD, Imricor Medical Systems Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IMR Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

234.5
P/S
P/S
Price to Sales
234.5
vs History
25
vs Industry
1
Median 3Y
92
Median 5Y
122.1
Industry
2.3
Forward
54.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-3
Median 5Y
-3.8
Industry
22
Forward
-14.8
More Details
Negative
P/OCF
P/OCF
Price to OCF
N/A
vs History
vs Industry
Median 3Y
-4.1
Median 5Y
-5.3
Industry
14.3
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
Median 3Y
-5.1
Median 5Y
-6
Industry
20
More Details
Negative
P/B
P/B
Price to Book Value
N/A
vs History
vs Industry
9
Median 3Y
-10.9
Median 5Y
2.4
Industry
2.2
More Details
238.8
EV/S
EV/S
Enterprise Value to Sales
238.8
vs History
20
vs Industry
1
Median 3Y
100
Median 5Y
120.4
Industry
2.4
Forward
55.3
More Details
Negative
EV/GP
EV/GP
Enterprise Value to Gross Profit
N/A
vs History
vs Industry
Median 3Y
-53.3
Median 5Y
-53.3
Industry
5
More Details
Negative
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
N/A
vs History
vs Industry
Median 3Y
-3.8
Median 5Y
-5.2
Industry
11.6
Forward
-15.2
More Details
Negative
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
N/A
vs History
vs Industry
Median 3Y
-3.7
Median 5Y
-4.9
Industry
15.9
Forward
-14.8
More Details
Negative
EV/OCF
EV/OCF
Enterprise Value to OCF
N/A
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-5.6
Industry
14.3
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
Median 3Y
-4.6
Median 5Y
-5.4
Industry
18
More Details
41.1
EV/IC
EV/IC
Enterprise Value to IC
41.1
vs History
11
vs Industry
1
Median 3Y
11.1
Median 5Y
13.6
Industry
1.8
More Details

Multiples Across Competitors

IMR Competitors Multiples
Imricor Medical Systems Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Imricor Medical Systems Inc
ASX:IMR
341.8m AUD 234.5 -7.6 -14.9 -14.1
US
Abbott Laboratories
NYSE:ABT
228.6B USD 5.4 16.9 22 31.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.5B USD 21.1 74.1 59.7 72.6
US
Boston Scientific Corp
NYSE:BSX
152.7B USD 8.7 75.1 35.4 49.3
US
Stryker Corp
NYSE:SYK
148.8B USD 6.4 52.1 25.7 31
IE
Medtronic PLC
NYSE:MDT
115.3B USD 3.4 24.7 13.8 19.6
DE
Siemens Healthineers AG
XETRA:SHL
51.7B EUR 2.2 24.7 13.9 19.3
US
Becton Dickinson and Co
NYSE:BDX
50.4B USD 2.4 33.2 13.2 24.7
US
Edwards Lifesciences Corp
NYSE:EW
45.9B USD 8.3 11 25.2 27.7
US
IDEXX Laboratories Inc
NASDAQ:IDXX
43.1B USD 11 48.1 34.1 38.1
US
Resmed Inc
NYSE:RMD
37.4B USD 7.4 28.5 20.3 23
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
Imricor Medical Systems Inc
ASX:IMR
Average EV/EBITDA: 26.3
Negative Multiple: -14.9 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
22
13%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
59.7
24%
2.5
US
Boston Scientific Corp
NYSE:BSX
35.4
21%
1.7
US
Stryker Corp
NYSE:SYK
25.7
12%
2.1
IE
Medtronic PLC
NYSE:MDT
13.8
7%
2
DE
Siemens Healthineers AG
XETRA:SHL
13.9
14%
1
US
Becton Dickinson and Co
NYSE:BDX
13.2
11%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
25.2
12%
2.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.1
12%
2.8
US
Resmed Inc
NYSE:RMD
20.3
12%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Imricor Medical Systems Inc
ASX:IMR
Average EV/EBIT: 33.7
Negative Multiple: -14.1 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
31.6
22%
1.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
72.6
26%
2.8
US
Boston Scientific Corp
NYSE:BSX
49.3
31%
1.6
US
Stryker Corp
NYSE:SYK
31
16%
1.9
IE
Medtronic PLC
NYSE:MDT
19.6
15%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
19.3
19%
1
US
Becton Dickinson and Co
NYSE:BDX
24.7
28%
0.9
US
Edwards Lifesciences Corp
NYSE:EW
27.7
12%
2.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38.1
12%
3.2
US
Resmed Inc
NYSE:RMD
23
14%
1.6

See Also

Summary
IMR intrinsic value, competitors valuation, and company profile.
DCF Valuation
IMR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IMR stock valuation using valuation multiples.
Wall Street Estimates
IMR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IMR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 267,400+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.